These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Molecular analysis of a thai beta-thalassaemia heterozygote with normal haemoglobin A2 level: implication for population screening. Author: Fucharoen S, Fucharoen G, Sanchaisuriya K, Pengjam Y. Journal: Ann Clin Biochem; 2002 Jan; 39(Pt 1):44-9. PubMed ID: 11853188. Abstract: BACKGROUND: This study aimed to characterize the molecular basis of a beta-thalassaemia heterozygote who had a normal haemoglobin A2 level. METHODS: Using haematological and molecular analyses, the alpha- and beta-globin genotypes in a Thai woman with normal haemoglobin A2 level, who was identified in a thalassaemia and haemoglobinopathy screening programme, were examined. RESULTS: The patient was positive for a 0.36% one-tube osmotic fragility test but negative for the dichlorophenolindophenol dye test for haemoglobin E. Haemoglobin A and A2 were observed on cellulose acetate electrophoresis with the haemoglobin A2 of 2.0%, compatible with an alpha-thalassaemia 1 carrier. Polymerase chain reaction analysis failed to detect alpha-thalassaemia 1 (South East Asian deletion). Beta-globin gene analysis detected a severe betao-thalassaemia allele with the 4 bp (-CTTT) deletion at codons 41/42. Further analysis of the alpha-globin gene identified the homozygosity of the 3.7 kb deletion alpha-thalassaemia 2. CONCLUSIONS: The patient was found to be an unusual case: a betao-thalassaemia carrier with a low haemoglobin A2 concentration, in combination with a homozygosity for the 3.7 kb alpha-thalassaemia 2 deletion. The approach used to characterize the patient and the result obtained in this report will prove useful for population screening of thalassaemia in regions where both alpha- and beta-thalassaemias are common.[Abstract] [Full Text] [Related] [New Search]